Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 3, 2014

View Archived Issues

Studies in animal model support idea of AAV-snRNA mediated exon-skipping for DMD

RaQualia presents preclinical findings on novel TRPM8 antagonists for neuropathic pain

Data and safety monitoring board recommends continuing phase III study of CPX-351

TG Therapeutics confirms start of trial of TGR-1202 with ibrutinib for B-cell malignancies

Ampio provides week 20 update on open-label portion of STRUT study of Ampion

Abeona Therapeutics raises funding to support Sanfilippo syndrome program

Unum Therapeutics initiates phase I trial of antibody-coupled T-cell receptor therapy

Homologous recombination deficiency score can predict response to niraparib in ovarian cancer

Lilly reports discovery and preclinical characterization of novel cathepsin S inhibitor

Nippon Shinyaku and Pfizer launch Tramal in Japan for cancer pain and chronic pain

Phase I results for recombinant ApoA-I Milano/phospholipid complex as treatment of atherosclerosis

Abivax completes first-in-human study of ABX-464

Actelion submits selexipag for approval in Europe

Eternity Bioscience patent details novel BRAF inhibitors

Dr August Wolff Group patent reports kappa-opioid agonists

N30 Pharmaceuticals presents novel CFTR modulators

Jiangsu Hengrui Medicine patents URAT1 inhibitors

Phase I data presented for CC-220 as treatment for SLE and other autoimmune diseases

Lung Therapeutics' LTI-01 receives FDA orphan drug designation

Pfizer acquires Baxter's marketed vaccines

Synageva BioPharma provides regulatory update for sebelipase alfa

Actinogen completes acquisition of Corticrine

Otsuka Pharmaceutical to acquire Avanir Pharmaceuticals

Momenta Pharmaceuticals to initiate clinical trial of M-923, a Humira biosimilar

EMA starts review of MAA of NPS Pharmaceuticals' Natpar

Cepheid receives FDA clearance to market norovirus diagnostic

FDA approves Xuanzhu Pharma's IND application for pirotinib

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...